Training future scientists in molecular and cellular biology
Predoctoral Training Program in Molecular and Cellular Biology
['FUNDING_TRAINING'] · UNIVERSITY OF COLORADO DENVER · NIH-11093663
This program at the University of Colorado is designed to train students in studying the biology of Down Syndrome, helping them gain hands-on experience and skills over 5-6 years, so they can become future leaders in medical research.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF COLORADO DENVER (nih funded) |
| Locations | 1 site (Aurora, UNITED STATES) |
| Trial ID | NIH-11093663 on ClinicalTrials.gov |
What this research studies
This program at the University of Colorado Anschutz Medical Campus focuses on training predoctoral students in molecular and cellular biology, particularly in relation to Down Syndrome. Students will engage in a flexible, rigorous curriculum that includes coursework and research thesis work over 5-6 years. They will participate in monthly research meetings, present their findings, and attend an annual symposium, fostering a collaborative environment to enhance their scientific skills. The program aims to develop future leaders in biomedical research.
Who could benefit from this research
Good fit: Ideal candidates for this program are predoctoral students interested in pursuing a Ph.D. in molecular biology with a focus on Down Syndrome.
Not a fit: Patients who are not pursuing a career in research or do not have an interest in molecular and cellular biology may not benefit from this program.
Why it matters
Potential benefit: If successful, this training program could lead to advancements in understanding and treating Down Syndrome and other related conditions.
How similar studies have performed: Similar training programs have successfully produced skilled researchers who have made significant contributions to biomedical science.
Where this research is happening
Aurora, UNITED STATES
- UNIVERSITY OF COLORADO DENVER — Aurora, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PREKERIS, RYTIS — UNIVERSITY OF COLORADO DENVER
- Study coordinator: PREKERIS, RYTIS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.